KML29
CAS: 1380424-42-9
Ref. 3D-FFC42442
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
Name:
KML29
Description:
KML29 is an amide compound that acts as a cannabinoid receptor agonist. It has been shown to be neuroprotective in in vitro experiments with cultured neurons and in vivo studies with rats injected with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) to induce Parkinson's disease. KML29 also inhibits neuronal death induced by the fatty acid, arachidonic acid, and exhibits anti-cancer activity in a mouse model of prostate cancer. KML29 has been shown to have an effective dose at 1 mg/kg for striatal dopamine release and locomotor activity. The drug also binds to the GABAA receptor and shows efficacy against anxiety, depression, and seizures.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
549.42 g/mol
Formula:
C24H21F6NO7
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
